more frequently expressed by relapsing AML, indicating its independent prognostic variable in acute myeloid leukemia.
However, in order to accomplish a reliable and reproducible assay for P-gp in disseminated hematologic malignancies such Introduction as AML and multiple myeloma, these measurements typically should be performed in well defined subpopulations of tumor Acute myeloid leukemia (AML) is usually treated with sequencells which can be selected by lineage-specific or tumor-spetial cycles of chemotherapy, followed by intensification and/or cific antigens. We have performed several studies in which consolidation therapy. In younger patients the probability of we compared different methods for the analysis of P-gp in long-term survival, associated with intensive chemotherapy multiple myeloma and AML. 19, 26, [31] [32] [33] [34] [35] Part of these results including high-dose cytarabine and/or allogeneic or autologwere previously published. A summary of these results will be ous stem cell transplantation is approximately 50% and may presented here. approach 80% in selected groups such as those with the t(8;21) and t(15;17) karyotypes. [1] [2] [3] [4] [5] [6] [7] [8] [9] Approximately 25% of younger patients and 40-50% of elderly patients with AML RNA-based assays are primary refractory to conventional chemotherapy. The majority of these patients have a very low probability of surIn our early studies of mdr1, we used the RNAse protection vival. In addition, many initially responsive patients relapse assay to determine the levels of mdr1RNA in bone marrow within 1-2 years. 1, 4, [10] [11] [12] and blood samples of patients with acute and chronic leukemThe cause of primary or acquired refractoriness to chemoias and multiple myeloma. The technical details of this assay therapy in AML is only partly understood.
and its modifications have been described in several publiAmong many different mechanisms of drug resistance, pleications. 19, 26, [31] [32] [33] [34] [35] The RNAse protection assay offers the otropic or multidrug resistance (MDR) has drawn specific advantage of specificity for mdr1 and the possibility to detect attention because of its possible significance for simultaneous different splicing products. It also gives information on the resistance to various cytostatic agents. MDR is encoded by the expression of not only mdr1, but also mdr3, which is fremdr1 gene which is situated at chromosome 7q21. P-glycoquently expressed in non-Hodgkin's lymphomas (NHL) and protein (P-gp) is a plasma membrane which acts as an ATPchronic lymphocytic leukemia (CLL). 36 There are however dependent drug efflux pump in cells exposed to cytotoxic several serious disadvantages of the RNAse protection assay. agents such as daunorubicin (DNR), vinca alkaloids
The problem which really limits the application of this assay (vincristine, vinblastine), and taxanes. High expression of is the large number of cells needed for RNA isolation and to mdr1 in cell lines can be transfered to sensitive cell lines by perform the assay with appropriate controls. Generally gene transfection or induced by exposure of sensitive cells to 10 × 10 6 nucleated cells are required for a complete analysis. increasing concentrations of one of these drugs. 13, 14 Because of the large amount of RNA that can be obtained, MDR expression is frequently observed in untreated AML the sensitivity of the assay is generally good. Even low cells, and may therefore be an important prognostic phenoexpression levels of mdr1RNA such as present in the RPMI type in poorly responding patients. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] In addition, MDR is 8226 DOX1 cell line can be detected and possible false-positive and false-negative results can be partly eliminated by making titrations. All this is however based on the assumption that a homogeneous cell population is used, which is not con- 40 The evaluation is however subject to personal interpretation and is always restricted to unattractive assay for large scale analysis of mdr1. Another disadvantage with the use of RNAse protection or Northern several hundreds of cells. Also, the fixation technique is of great influence on the staining intensity, with formaldehyde blot assays is the fact that it will require at least several days or even weeks to obtain a result. The assays are laborious and resulting in dull staining and acetone generally producing more bright staining. For this reason, slides from different labfrequently not accessable for clinicians.
Many of these objections can also be used against the more oratories cannot easily be compared except if identical fixation and staining procedures are used. Still, immunocytochrecently developed RT-PCR assay, which also analyses RNA expression. However, this assay has been developed and emistry is an important method of P-gp analysis, in particular for diagnostic procedures and for staining of tissue slides and adapted to be used with relatively low numbers of cells. In our hands approximately 10 5 AML cells are needed for a bone marrow biopsies, provided that the procedure will be standardized according to internationally accepted guidelines. reliable assay. This requirement offers the possibility to perform the assay on preselected cells, for example cells which This is certainly a prerequisite for large clinical trials where immunocytochemistry is the only method which meets wide have been sorted on the basis of specific membrane antigens. In those tumors, in which lineage-and tumor-specific antigens acceptance and applicability. Only then can the value of this assay be fully appreciated. Immunocytochemistry can be are expressed, cells can be sorted and purified. In our group this has been done with CD38
+ multiple myeloma cells and combined with counterstaining cytochemistry such as MayGrü nwald-Giemsa or acid phosphatase, in order to further CD56 + NK cells. Such an approach could also be taken to select and to purify to some extent AML cells by using the define the morphology of positive cells. CD34 antigen, or in a similar approach to select for B lineage differentiation markers in acute lymphoblastic leukemia, such as CD19 or CD20.
Flow cytometry-based assays of P-glycoprotein These assays are all based on expression levels of mdr1RNA. The results are not predictive for the actual Flow cytometry has provided the clinical hematologist with a whole range of new diagnostic tests, including a better phenoexpression of the relevant protein, P-glycoprotein and the drug efflux function. Although it has been claimed that RT-PCR is typic characterization of the various subclasses of acute leukemias. For the detection of MDR in acute leukemias, flow cytoa reliable assay for the functional expression of mdr1, no substantial study has yet been published to prove this point. 37 metry is probably the most valuable tool which is presently available. The reason for this is the multiplicity of analyses Therefore, the main advantage of mdr1RNA based assays remains their specificity for mdr1. Especially when such an that can be performed simultaneously on single cells or on samples containing large numbers and/or subpopulations of assay is combined with (functional) methods of P-glycoprotein analysis, the combined results can be used to provide definite cells. Flow cytometric analysis of P-glycoprotein can be performed with different approaches in order to obtain different proof that the resistance is caused by mdr1 rather than by other ABC transporters.
outcome parameters which each represent either P-gp expression or function. 18, 31, 34, 43 Qualitative expression of P-gp using monoclonal antibodies that recognize extracellular epitopes of P-gp can be performed Immunocytochemistry for P-glycoprotein detection in unfixed cells. Such antibodies are MRK16, 4E3, or MM417. FITC-labeled secondary antibodies are used to produce a flu-AML like many other hematological tumors is characterized by an easy access to tumor cells during all phases of active orescence signal. Instead Texas Red can also be used, thus allowing triple fluorescence while reducing the background disease. This is one reason why the expression of P-gp in AML has been studied extensively. Moreover, AML is treated with fluorescence. The results are usually expressed as a proportion of cells that are positive, ie show fluorescence above the backseveral mdr1-related drugs, including anthracyclines, mitoxantrone and etoposide.
ground level. The main disadvantage of this analysis is the variable definition of positivity between different investigators. Immunocytochemistry of AML blasts using monoclonal antibodies against P-glycoprotein such as MRK16, C219, JSB1, Any study using this assay should perform calibration standards such as specified beads to define the flow cytometer. In C494 and 4E3 has been performed in many studies. [38] [39] [40] [41] [42] Generally, such a procedure can not be applied on unseparated addition control cell lines, preferably stable, well established sensitive and MDR cell lines, should always be analyzed with bone marrow or blood cells, and a purification step is necessary. After Ficoll separation, cytospins can be prepared which the clinical sample in order to correct for interassay variation. It should be noted that standard cell lines should have a level can be stained. We have performed this procedure in over 250 AML and MM samples with a satisfying staining intensity of P-gp expression which is comparable to clinical AML samples, in order to avoid any amplification difficulties during even if thawed, viable cells were used after cryopreservation. The main advantage of this procedure is, that the morphology the analysis. Such cell lines are for example the human myeloma cell line RPMI 8226dox1 and the KB8. remains intact and that P-gp staining can be evaluated in individual cells. It has been found recently, however, that not all Quantitative analysis of P-gp is meant to determine the level of P-gp expression. This result is obtained by measuring the antibodies give uniform results with immunocytochemistry. The C219 monoclonal antibody, for example, which binds to mean or median channel shift of a previously gated cell population, when comparing the relative fluorescence of P-gp-spea cytoplasmic epitope of P-gp, produces a high background staining in AML blasts which subsequently can be interpreted cific Moab and the matched control antibody. Usually the Kolmogorov-Smirnov statistics are used to calculate the stainas (false) positive samples.
A major disadvantage of immunocytochemistry in general, ing intensity. However, this approach may insufficiently address the wide variability of P-gp expression. Consequently, but for P-gp in particular is its lack of quantification criteria. cells with either a high or a low level of expression may have used a fixed interval of 90 min between the initial incubation of rhodamine in the presence of SDZ PSC 833, followed by a small contribution to the overall sample assessment. Samples which have a small proportion of highly P-gpa washing procedure, until the moment of intracellular rhodamine 123 assessment. Again, the analysis of clinical samples positive cells may incorrectly be regarded as negative. For a correct and reliable analysis of P-gp expression different should be performed simultaneously with standard cell lines. The results are usually expressed as the efflux ratio of rhodaantibodies may be employed.
Flow cytometry further has a definitive advantage in its mine or another dye/drug as a function of SDZ PSC 833 or another modulator at a fixed concentration (Figure 1) . Particapacity to analyze large numbers of cells and to recognize different subpopulations of cells with heterogeneous P-gp cular attention should be given to the presence of protein (serum) in the conditioned medium, since many modulators expression.
The most specific analysis of P-gp with flow cytometry is are partly inactivated when bound to serum proteins. Interestingly, the functional assay of P-gp using the rhodathe measurement of the efflux function of the protein. Usually these techniques are based on the determination of either flumine 123 efflux ratio is not always in agreement with the MRK16-based P-gp detection on the same cells, using flow orescent dye or drug accumulation or the efflux measurement of these in intact cells. As fluorescent dyes, rhodamine 123, cytometry. Leith et al 43 have observed both MRK16-positive/efflux negative and MRK16-negative/efflux-positive DiOC2, calcein-AM or Hoechst 33342 can be used. The fluorescent anthracyclines daunorubicin, doxorubicin and idarucases, which may reflect the presence of alternative efflux mechanisms which have not yet been identified. bicin may also serve this purpose. The choice for a functional probe of P-gp depends on several factors. Rhodamine 123 is a mitochondrial dye which is transported across the mitochondrial lipid membrane as well as across the plasma memDouble fluorescence of P-glycoprotein with lineage-specific antigens brane, while calcein is a cytoplasmic marker, which is transported across the plasma membrane only. Hoechst 33342 is a DNA binding dye, and its fluorescence may be quenched For a better understanding of the role of P-gp for AML prognosis, it is necessary to investigate P-gp expression and funcas it is intercalated. DiOC2 is a membrane potential indicator and seems a reliable dye for P-gp transport function in cell tion in specific subsets of cells, for example cells that express immature antigens (CD34, c-kit, HLA-DR), or cells with other membranes. These dyes further differ with respect to the fluorescent properties, the equilibration characteristics, the rate specific phenotypes such as favorable/unfavorable karyotypes, in vitro spontaneous proliferation or other poor prognostic of membrane transport and the optimal pH at which they are transported. The dyes may be used in intact, unfixed cells to measure the maximum or equilibrium intracellular concentration (accumulation assay) or to measure the efflux through P-gp after prior exposure of these cells to the dye, followed by placement in a dye-free medium. At present it is not known which dye is preferable, although most investigators have been using rhodamine 123. Of particular interest is the fact that viable cells have to be used. This means that before analysis, fresh or cryopreserved AML cells should be put through Ficoll-Hypaque and that dead cells should be excluded from the flow analysis. There is however a considerable day-to-day variation of this assay, in particular if absolute fluorescence units are used to calculate the outcome of dye accumulation or efflux assays, for which reason the inter-sample variation may impose serious difficulties in the analysis of large numbers of clinical samples. This problem can at least be partly evaded by using P-gp-blocking agents or reversal agents such as verapamil, cyclosporin or its non-immunosuppressive derivative, SDZ PSC 833. Of these, SDZ PSC 833 is a specific inhibitor of P-gp which completely blocks the efflux of rhodamine 123 at concentrations of 1-2 M. The absolute ratio of the intracellular accumulation of rhodamine 123 with or without SDZ PSC 833 represents an objective and reproducible indicator of the P-gp-mediated efflux of the dye. Still, problems may then be encountered in samples with only slightly increased P-gp expression, where no difference may be observed in samples if SDZ PSC 833 is added. Therefore the use of efflux ratio instead of accumulation ratio is preferable in particular for cells with a low level of resistance. The proper interpretation of this assay depends on the predefined times that are allowed for efflux of rhodamine 123 in vitro in the choose a time when the maximum efflux is reached. We have phenotypes. At present there is only limited information on of these antigens, usually the differentiation-specific antigen should be directly labeled, for example with FITC or phycowhether these adverse characteristics are independently expressed or if there exists a possible association. Those studerythrin. P-gp should be detected with a monoclonal antibody that recognizes an extracellular epitope such as MRK16 with ies that were published mostly used separate procedures for the analysis of differentiation antigens or other genes and Pa secondary antibody that carries another fluorescence label, for example Texas Red. Details of the technical assay have gp. Generally, arbitrary cut-off levels were used to define positive samples in such studies and therefore they do not provide been published before. 31, 32 It is important to adjust for background fluorescence of the conclusive evidence about co-expression of P-gp with other adverse prognostic antigens. There are however several CD34-antibody's label when analyzing MRK16. For the same reason it was not possible in our hands to combine rhodamine possible approaches to investigate this issue.
First, double expression of P-gp with other extracellular epior daunorubicin accumulation with MRK16. Several investigators have attempted to combine P-gp detection together topes can be performed such as P-gp with CD34 or c-kit in AML, or P-gp with CD38 or CD19 in multiple myeloma with cytoplasmic or nuclear antigens or they have used P-gp antibodies that recognize intracellular epitopes. In both cases, (Figure 2) . In order to perform a technically reliable assay, one the plasma membrane has to be permeabilized, which may significance of mdr1, it should be investigated in AML cells only, thus excluding analytical techniques based on bulk lead partly to destruction of P-gp epitopes. We have combined MRK16 with cytoplasmic light chain detection in multiple samples. Moreover, all significant prognostic variables should be studied in the same samples including conventional karymyeloma samples using Permeafix (Ortho, Raritan, NJ, USA), and we have found that although the assay can be performed otyping, analysis of differentiation antigens (CD34), morphologic classification (M0) and other variables. In addition it to recognize P-gp expressing clonal plasma cells, there may be a loss of MRK16 related fluorescence (Sonneveld, unpub- seems preferable to investigate other mechanisms of MDR, as well as cytarabine dose and metabolism. lished results). Furthermore, it is important to define the optimal incubation conditions for the P-gp antibodies and to select the preferred order of incubation steps. In our experience both fresh or viably cryopreserved cells can be used to perReferences form these studies. 34 With these studies we have observed that CD34-positive subsets of AML blasts have a higher expression 
